VP Finance, Principal Financial and Accounting Officer · Whitehawk Therapeutics, Inc. (WHWK)

Regina Marek

A named executive officer of Whitehawk Therapeutics in every fiscal year CompBrief holds from FY2018 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$356,175

Salary $278,100Bonus $120,000

FY2019: $485,590

3rd of 3 named executive officers at Whitehawk Therapeutics by FY2020 total.

3 named officers on file for Whitehawk Therapeutics, FY2020

Regina Marek’s pay file — $29

  • 3 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Whitehawk Therapeutics’s whole pay program stands against its peers

  • Whitehawk Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on WHWK→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed June 9, 2021 (DEF 14A).

Free

Get Regina Marek’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Regina Marek compensation by year

Whitehawk Therapeutics Summary Compensation Table · all 3 fiscal years held
In US dollars, as Whitehawk Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018FY2019FY2020
Salary$93,750$244,643$278,100
Bonus$0$0$120,000
Stock awards$0$0—
Option awards$171,357$168,866$29,057
Non-equity incentive$36,563$71,708$48,668
Pension and deferred compensation$0$0—
All other$155$373$350
Total$301,825$485,590$356,175

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Whitehawk Therapeutics, Inc. DEF 14A filed June 9, 2021, accession 0001564590-21-032185, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Whitehawk Therapeutics, Inc. filed document, accession 0001564590-21-032185. Every figure is read from that document and cited to the page and table it appears in. Filed June 9, 2021.

$302K
$486K
$356K
FY18
FY19
FY20
SalaryBonusNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
Option76,650—$1.04
Option93,000—$0.52
Option23,998—$0.56
Option33,333—$3.49
Option16,250—$3.27

Per the Outstanding Equity Awards at Fiscal Year-End table in Whitehawk Therapeutics, Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

Whitehawk Therapeutics’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Joseph GardnerPresident and Principal Executive Officer$590,823
Kevin PetersChief Scientific and Medical Officer$486,267
Regina Marek · this pageVP Finance, Principal Financial and Accounting Officer$356,175

The full Whitehawk Therapeutics compensation record

free company brief

This page is one person within Whitehawk Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Whitehawk Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Regina Marek's compensation dossier · One-time report. No refunds.